Nadal, Aquilla Loraine A.

HRN: 24-78-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/08/2024
10/15/2024
300 MG
IV
Q6HRS
CELLULITIS AT LEFT LEG
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: